Aktienanalyse wird geladen …
ISRG · NASDAQ · Medical Instruments & Supplies · USA
405,18 $
| Geschäftsjahr | Umsatz | Nettogewinn | EPS (GAAP) | Aktien (verw., gesamt) | SBC in Stück | Rückkäufe (ca.) | Bruttomarge | Nettomarge | FCF / Aktie | SBC / Aktie | Dividende / Aktie |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 10,06 Mrd. | 2,86 Mrd. | 7,87 $ | 362,7 Mio. | 1,9 Mio · 0,5 % | 1,2 Mio · 0,3 % | 66 % | 28,4 % | 6,87 $ | 2,17 $ | — |
| 2024 | 8,35 Mrd. | 2,32 Mrd. | 6,42 $ | 362 Mio. | 1,7 Mio · 0,5 % | — | 67,5 % | 27,8 % | 3,60 $ | 1,87 $ | — |
| 2023 | 7,12 Mrd. | 1,8 Mrd. | 5,03 $ | 357,4 Mio. | 1,5 Mio · 0,4 % | 6,1 Mio · 1,7 % | 66,4 % | 25,2 % | 2,10 $ | 1,66 $ | — |
| 2022 | 6,22 Mrd. | 1,32 Mrd. | 3,65 $ | 362 Mio. | 1,3 Mio · 0,3 % | 5,1 Mio · 1,4 % | 67,4 % | 21,3 % | 2,65 $ | 1,42 $ | — |
| 2021 | 5,71 Mrd. | 1,7 Mrd. | 4,66 $ | 365,8 Mio. | 1,1 Mio · 0,3 % | — | 69,3 % | 29,9 % | 4,78 $ | 1,23 $ | — |
| 2020 | 4,36 Mrd. | 1,06 Mrd. | 2,94 $ | 361 Mio. | 1 Mio · 0,3 % | — | 65,7 % | 24,3 % | 3,17 $ | 1,10 $ | — |
| Quartal | Umsatz | Nettogewinn | EPS | Aktien (verw., gesamt) | Bruttomarge | Nettomarge | FCF / Aktie |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2,89 Mrd. | 818,1 Mio. | 2,29 $ | 357,3 Mio. | 67,8 % | 28,3 % | 2,65 $ |
| Q1 2026 | 2,77 Mrd. | 821,5 Mio. | 2,28 $ | 359,8 Mio. | 66,1 % | 29,7 % | 2,25 $ |
| Q4 2025 | 2,87 Mrd. | 794,8 Mio. | 2,21 $ | 360,4 Mio. | 66,4 % | 27,7 % | 2,01 $ |
| Q3 2025 | 2,51 Mrd. | 704,4 Mio. | 1,95 $ | 361,8 Mio. | 66,4 % | 28,1 % | 2,03 $ |
| Q2 2025 | 2,44 Mrd. | 658,4 Mio. | 1,81 $ | 364,1 Mio. | 66,3 % | 27 % | 1,54 $ |
| Q1 2025 | 2,25 Mrd. | 698,4 Mio. | 1,92 $ | 364,6 Mio. | 64,7 % | 31 % | 1,28 $ |
| Q4 2024 | 2,41 Mrd. | 685,7 Mio. | 1,89 $ | — | 68 % | 28,4 % | 1,41 $ |
| Q3 2024 | 2,04 Mrd. | 565,1 Mio. | 1,56 $ | 362,7 Mio. | 67,4 % | 27,7 % | 1,26 $ |
Intuitive Surgical Inc. is a medical technology company focused on robotic-assisted and minimally invasive care. Intuitive Surgical develops, manufactures, and markets the da Vinci surgical systems, which are used by surgeons to perform procedures with enhanced precision through a minimally invasive approach. The company also offers the Ion endoluminal system, extending its platform into diagnostic endoluminal procedures and lung biopsy applications. In addition to its core systems, Intuitive Surgical supports hospitals and healthcare providers with instruments, accessories, and services that help integrate robotic surgery into clinical workflows. Its products serve a broad range of specialties, including general surgery, urology, gynecology, thoracic surgery, and diagnostic care. Headquartered in Sunnyvale, California, Intuitive Surgical plays a significant role in the global healthcare equipment market by advancing the adoption of robotic systems in modern surgical and diagnostic settings.
WebsiteMit einem Konto testest du Glancefield Pro 3 Tage gratis und bewertest ISRG und jede andere Aktie unbegrenzt.